In the 1995 cult classic, Clueless, when Josh was helping Cher learn to drive he asked her if she wanted to practice parking. Her reply?
“What’s the point? Everywhere you go has valet.”
Maybe in Beverly Hills; but not in my hometown of Chicago. Fast forward two decades later and Elon Musk is finally making all of my Clueless dreams come true. The new technology that Tesla Motors Inc (NASDAQ: TSLA) is bringing to market will literally allow me to roll up to the Cubs’ World Series (I’m hoping Musk can make this happen, too), exit my car right at the corner of Clark and Addison, and have the car enter “park seek” mode and automatically look for a parking place. After the Cubs win and I’ve finished singing “Go Cubs Go,” I’ll be able to casually stroll outside and summon my vehicle.
what to invest in: CytRx Corporation(CYTR)
Advisors' Opinion:- [By Roberto Pedone]
Another under-$10 biotechnology player that's starting to trend within range of triggering a major breakout trade is CytRx (CYTR), which has an oncology pipeline that includes two programs in clinical development for cancer indications: aldoxorubicin and tamibarotene. This stock has been moving to the upside during the last three months, with shares up by 21%.
If you take a look at the chart for CytRx, you'll notice that this stock has been trending sideways inside of a consolidation chart pattern for the last two months, with shares moving between $2.27 on the downside and $2.68 on the upside. That consolidation pattern has occurred right above this stock's 50-day and 200-day moving averages. Shares of CYTR have now started to break out above some near-term overhead resistance at $2.49 a share. That move is quickly pushing CYTR within range of triggering an even bigger breakout trade above the upper-end of its recent sideways trading chart pattern.
Market players should now look for long-biased trades in CYTR if it manages to break out above some near-term overhead resistance levels at $2.68 to $2.80 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 154,838 shares. If that breakout triggers soon, then CYTR will set up to re-test or possibly take out its next major overhead resistance levels at $3.20 to $4 a share.
Traders can look to buy CYTR off any weakness to anticipate that breakout and simply use a stop that sits right below its 200-day at $2.33 a share or below more support at $2.27 a share. One can also buy CYTR off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
what to invest in: CRB Futures Index(CR)
Advisors' Opinion:- [By Lisa Levin]
Crane Co. (NYSE: CR) shares were also up, gaining 12 percent to $67.56 on stronger-than-expected Q3 earnings.
Equities Trading DOWN - [By Monica Gerson]
Crane Co. (NYSE: CR) is expected to post its quarterly earnings at $0.86 per share on revenue of $644.60 million.
Oceaneering International (NYSE: OII) is projected to post its quarterly earnings at $0.35 per share on revenue of $641.85 million.
what to invest in: Helios and Matheson Analytics Inc(HMNY)
Advisors' Opinion:- [By Cameron Saucier]
Helios and Matheson Analytics Inc. (Nasdaq: HMNY) is an information technology company that provides its clients predictive analytics. The company uses big data for most of its software and operates within the financial services, insurance, and healthcare industries. HMNY is up 278% YTD after it announced a strategic merger with a GPS application company, called RedZone Maps. RedZone is known for mapping crime in major cities. News of the merger sent HMNY climbing over 1,000% from $1.11 per share to $13.75 per share over the course of a week. The stock has since fallen to $5.23 per share as of Monday intraday.
what to invest in: Ubiquiti Networks, Inc.(UBNT)
Advisors' Opinion:- [By Jon C. Ogg]
Ubiquiti Networks Inc. (NASDAQ: UBNT) was given a cautious Neutral rating as well, and it had the least negative bias in Garcha’s call. He said:
- [By Mani]
Ubiquiti Networks, Inc. (NASDAQ:UBNT) shares have been in rally mode, particularly since reporting strong quarterly results in August, gaining 57 percent. Over the past three months, shares have climbed nearly 100 percent versus a 9 percent gain in the NASDAQ.
what to invest in: Liberty Interactive Corporation(QVCA)
Advisors' Opinion:- [By WWW.THESTREET.COM]
QVC (QVCA) was upgraded to buy from neutral at Bank of America/Merrill Lynch. $25 price target. The company can turn its sales around and deserves a higher multiple, analysts said.
- [By Scott Rubin]
Stock gainers included Mercadolibre Inc (NASDAQ: MELI), up almost 14 percent, and Nu Skin Enterprises, Inc. (NYSE: NUS), which added 12 percent. The positive gains in both stocks were due to strong earnings reports. Shares of Liberty Interactive Group (NASDAQ: QVCA) plunged almost 22 percent on Friday due to disappointing sales growth in its fiscal second quarter. Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) lost 16 percent after a disappointing study involving its Opdivo drug.
what to invest in: Exelon Corporation(EXC)
Advisors' Opinion:- [By Horizon Investments]
For the past year, Exelon Corp. (EXC) has had a roller coaster ride, with the stock having plummeted 15% since September 2012 - the company had announced a dividend cut of 41%, which led to a drop in the share price. Separately, the recent weak PJM auction prices did not bode well for the company. However, I believe the worst is priced in the stock price, and the company's management is committed to improving its financial flexibility and cost structure in order to strengthen its financial performance. Also, the company is planning to incur capital expenditure (CAPEX) in the upcoming years, which will result in rate base growth for Exelon.
- [By Monica Gerson]
Exelon Corporation (NYSE: EXC) is expected to report its quarterly earnings at $0.68 per share on revenue of $7.52 billion.
CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion.
- [By Monica Gerson]
Analysts are expecting Exelon Corporation (NYSE: EXC) to have earned $0.68 per share on revenue of $7.52 billion in the latest quarter. Exelon shares rose 0.34 percent to close at $35.38 on Thursday.
